Health Care

Scientists expect cure for cancer in 1 year

The drug called as "MuTaTo" (multi-target toxin) now in development by AEBi under the leadership of CEO Dr. Ilan is essentially "on the scale of a cancer antibiotic-a disruptive technology of the highest order", which shall be the potential game changer against the world's deadliest disease "Cancer". Once the treatment is over, the cells generate cancer again.

The treatment will not be affected by mutations by using at least three targeting peptides on the same structure with a strong toxin. The experiment showed inhibited human cancer cell growth and had no effect on healthy mice cells, according to the paper.

A team of Israeli scientists is claiming that it has developed a medication that has the power to cure all types of cancer.

"Our results are consistent and repeatable", Aridor said.

As news stories hailing the discovery spread online, other cancer experts urged the public to approach the report with caution.

The team of scientist have also claimed to make the first-ever cure for the deadly disease as a cheap, effective with no or minimal side-effects. We've heard of cure-alls for cancer in the past that unfortunately have not panned out. This oversimplifies the fact that cancer is more than 200 different diseases, which behave differently and pose different treatment challenges.

Another doctor, meanwhile, told the Daily Mail that it's not likely there will ever be a surefire cure for cancer.

The treatment, known as MuTaTo, is said to essentially be a "cancer antibiotic" that boasts "disruption technology of the highest order".

Professor Justin Stebbing, an expert in cancer medicine and oncology at Imperial College London, U.K., told Newsweek that research at the Weizmann "is some of the best in the world".

It hasn't been trialed on humans yet, but has seen incredible success on animals. So let's be cautiously optimistic, I just don't want to provide false hope for cancer patients.

Dr Vince Luca, assistant professor of Cancer Biology at Moffitt Cancer Centre, echoed the concerns, saying that "very few peptide-based drugs have received FDA approval for oncology indications".

A cancer cell (white) being attacked by two cytotoxic T cells (red). More than 99.9 percent of the molecular processes within them are the same as the normal cells they originate from. Mutations in the targets - or downstream in their physiological pathways - could make the targets not relevant to the cancer nature of the cell, and hence the drug attacking it is rendered ineffective...

A lot of cytotoxic anticancer treatments aim at fast-growing cells but cancer stem cells do not grow fast and are able to escape the treatments. "Painful lessons have been learned trying to exploit drugs that do not target founding mutations".

If MuTaTo is successful, it has the potential to revolutionize cancer treatment and give hope to the millions of people who are diagnosed each year.

Like this



31 January 2019
Foxconn may shelve plan to make LCD panels at $10B Wisconsin factory
The plans, and the jobs, may now be curtailed or even killed. "Today we're seeing the results of the pro-America agenda. The state of Wisconsin had agreed to support the project with controversial incentives worth more than $3bn.

31 January 2019
'Zombieland' Cast Uses 10-Year Challenge to Reveal Sequel Title
Of the plot, Variety says "the sequel centres on the comic mayhem that stretches from the White House and through the heartland ". Thanks to a clever poster reveal, we now know the name of the " Zombieland " sequel: It's " Zomebieland: Double Tap ".

30 January 2019
Netflix sends a message to viewers: stop lusting after 'hot' Ted Bundy
Yet when he was charged, many failed to believe that such a handsome and charming man could in fact be a murderous psychopath. Speaking to People , the director said that he was intrigued by how Bundy did not exhibit traits typical of a serial killer.

30 January 2019
Facebook has been paying teens for unfettered access to their data
Now, Apple is hitting back at the company for abusing their policies and making sure their stance on the discovery is known. The company acquired a VPN app called Ovano in 2014 that promised to help users secure their Wifi traffic for free.

30 January 2019
US pushes UN Security Council to back Venezuela's Guaido
On Wednesday, President Donald Trump recognized the opposition leader and head of Venezuela's parliament as the interim president. Mexican President Andres Manuel Lopez Obrador said yesterday his administration would be willing to mediate.

30 January 2019
Painting stolen from Moscow gallery as witnesses watch
The Ministry of Culture said it had ordered security checks at all of Russia's "top flight" museums. It also praised authorities for recovering the painting.

30 January 2019
Taoiseach to speak to British PM following Commons vote
The Irish Government has said the UK's Brexit Withdrawal Agreement is not open for re-negotiation. Taoiseach Leo Varadkar is expected to speak with British Prime Minister Theresa May this morning.

30 January 2019
Anthony Davis will only re-sign with the Lakers
And they waited until after the season to make the move - as opposed to pulling the trigger on a trade at the February deadline. Davis can become an unrestricted free agent in 2020 if he doesn't sign an extension.

30 January 2019
Ariana Grande Reacts After Fans Notice She's Mistranslated Her Tattoo
Meanwhile, she's still riding the high of the success of " 7 Rings ", along with previously released track, " Thank U, Next ". She jokingly added , "Also.... huge fan of tiny bbq grills".

30 January 2019
Valve: Removing Metro Exodus From Steam Is 'Unfair'
That said, it looks to be an inevitability, with the likes of Ubisoft's The Division 2 also being an Epic Games Store exclusive. Customers in the United States who buy Metro Exodus from Epic will pay $50, a full $10 discount over the Steam price.